Royal Bank of Canada’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-4,304
| Closed | -$68K | – | 7197 |
|
2024
Q1 | $68K | Sell |
4,304
-16,115
| -79% | -$255K | ﹤0.01% | 4954 |
|
2023
Q4 | $329K | Buy |
20,419
+8,722
| +75% | +$141K | ﹤0.01% | 4141 |
|
2023
Q3 | $148K | Buy |
11,697
+3,602
| +44% | +$45.6K | ﹤0.01% | 4594 |
|
2023
Q2 | $114K | Buy |
8,095
+1,824
| +29% | +$25.7K | ﹤0.01% | 4794 |
|
2023
Q1 | $97K | Sell |
6,271
-2,727
| -30% | -$42.2K | ﹤0.01% | 4828 |
|
2022
Q4 | $147K | Buy |
8,998
+8,433
| +1,493% | +$138K | ﹤0.01% | 4701 |
|
2022
Q3 | $10K | Buy |
565
+312
| +123% | +$5.52K | ﹤0.01% | 5948 |
|
2022
Q2 | $3K | Sell |
253
-2,190
| -90% | -$26K | ﹤0.01% | 6414 |
|
2022
Q1 | $23K | Sell |
2,443
-6,080
| -71% | -$57.2K | ﹤0.01% | 6049 |
|
2021
Q4 | $83K | Buy |
8,523
+8,004
| +1,542% | +$77.9K | ﹤0.01% | 5540 |
|
2021
Q3 | $18K | Buy |
519
+474
| +1,053% | +$16.4K | ﹤0.01% | 6228 |
|
2021
Q2 | $2K | Sell |
45
-2,119
| -98% | -$94.2K | ﹤0.01% | 6767 |
|
2021
Q1 | $97K | Buy |
2,164
+2,139
| +8,556% | +$95.9K | ﹤0.01% | 5007 |
|
2020
Q4 | $1K | Buy |
+25
| New | +$1K | ﹤0.01% | 6429 |
|
2020
Q3 | – | Sell |
-35
| Closed | -$2K | – | 6438 |
|
2020
Q2 | $2K | Sell |
35
-975
| -97% | -$55.7K | ﹤0.01% | 5848 |
|
2020
Q1 | $41K | Sell |
1,010
-938
| -48% | -$38.1K | ﹤0.01% | 4764 |
|
2019
Q4 | $121K | Buy |
+1,948
| New | +$121K | ﹤0.01% | 4408 |
|
2019
Q3 | – | Sell |
-341
| Closed | -$8K | – | 6239 |
|
2019
Q2 | $8K | Buy |
+341
| New | +$8K | ﹤0.01% | 5257 |
|
2018
Q4 | – | Sell |
-266
| Closed | -$10K | – | 6207 |
|
2018
Q3 | $10K | Buy |
266
+208
| +359% | +$7.82K | ﹤0.01% | 5387 |
|
2018
Q2 | $2K | Buy |
+58
| New | +$2K | ﹤0.01% | 5698 |
|
2018
Q1 | – | Sell |
-81
| Closed | -$2K | – | 6054 |
|
2017
Q4 | $2K | Buy |
+81
| New | +$2K | ﹤0.01% | 5551 |
|